Skip to main content

Welkom bij THIM Hogeschool voor Fysiotherapie & Bohn Stafleu van Loghum

THIM Hogeschool voor Fysiotherapie heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen. Je kunt je links eenvoudig registreren. Met deze gegevens kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL. Heb je een vraag, neem dan contact op met helpdesk@thim.nl.

Registreer

Om ook buiten de locaties van THIM, thuis bijvoorbeeld, van Mijn BSL gebruik te kunnen maken, moet je jezelf eenmalig registreren. Dit kan alleen vanaf een computer op een van de locaties van THIM.

Eenmaal geregistreerd kun je thuis of waar ook ter wereld onbeperkt toegang krijgen tot Mijn BSL.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Top
Gepubliceerd in:

01-02-2010 | original article

Evaluation of global left ventricular function assessment of non-fluorescent electromechanical endocardial mapping compared with biplane left ventricular contrast angiography

Auteurs: E-S Tan, P. A. Van der Vleuten, G. A. J. Jessurun, R. A. Tio, F. Zijlstra, I. C. Van Gelder

Gepubliceerd in: Netherlands Heart Journal | Uitgave 2/2010

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Extract

Prognosis after ST-elevation myocardial infarction (STEMI) is closely related to cardiac volumes, myocardial mass and global left ventricular (LV) function, expressed as left ventricular ejection fraction (LVEF).1 Accurate assessment of these parameters is required for the prediction of prognosis in individual patients as well as in entire cohorts.2-4 The introduction of primary percutaneous intervention (PCI) for STEMI has been proven to increase LV rest function in this patient category. However, some patients suffer from symptoms of heart failure as a result of post-infarct deterioration of left ventricular function. One strategy to improve left ventricular function after reperfusion therapy is bone marrow-derived progenitor cell infusion.5-7 The optimal route of delivery is still under debate.8,9 Commercially available non-fluoroscopic electromechanical endocardial mapping systems (EEM) that measure both wall motion and electrical activity can aid the interventional cardiologist by providing on-line anatomical and functional information without excessive radiation exposure. In addition, these systems can be fitted with dedicated (cell) injection catheters. This technique has proved to be safe and feasible both in the cell- and gene-delivery setting.5,10-12 It was hypothesised that besides facilitating cell delivery, the generated maps could provide global LV function assessment, which can be used to measure efficacy of the applied therapy. Since EEM is being used ever more frequently in clinical practice, it is increasingly relevant to assess its diagnostic accuracy for analysis of global LV function parameters. Although there have been many studies focusing on the differentiation between viable and non-viable myocardium, to date only a few studies focusing on the diagnostic accuracy of EEM for assessment of global LV function have been published.13,14 Therefore, we sought to investigate the diagnostic accuracy of EEM in a cohort of post-STEMI patients undergoing routine cardiac catheterisation.
Literatuur
1.
go back to reference Van der Vleuten PA, Rasoul S, Huurnink W, Van der Horst IC, Slart RH, Reiffers S, et al. The importance of left ventricular function for long-term outcome after primary percutaneous coronary intervention. BMC Cardiovasc Disord. 2008;8:4. Van der Vleuten PA, Rasoul S, Huurnink W, Van der Horst IC, Slart RH, Reiffers S, et al. The importance of left ventricular function for long-term outcome after primary percutaneous coronary intervention. BMC Cardiovasc Disord. 2008;8:4.
2.
go back to reference Moise A, Bourassa MG, Theroux P, Taeymans Y, Pasternac A, Campeau L, et al. Prognostic significance of progression of coronary artery disease. Am J Cardiol. 1985;55:941–6. Moise A, Bourassa MG, Theroux P, Taeymans Y, Pasternac A, Campeau L, et al. Prognostic significance of progression of coronary artery disease. Am J Cardiol. 1985;55:941–6.
3.
go back to reference Emond M, Mock MB, Davis KB, Fisher LD, Holmes DR Jr, Chaitman BR, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645–57. Emond M, Mock MB, Davis KB, Fisher LD, Holmes DR Jr, Chaitman BR, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645–57.
4.
go back to reference Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561–6. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561–6.
5.
go back to reference Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003;107:2294–302. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003;107:2294–302.
6.
go back to reference Beeres SL, Bax JJ, Dibbets-Schneider P, Stokkel MP, Fibbe WE, van der Wall EE, et al. Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction. Am J Cardiol. 2007;100:1094–8. Beeres SL, Bax JJ, Dibbets-Schneider P, Stokkel MP, Fibbe WE, van der Wall EE, et al. Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction. Am J Cardiol. 2007;100:1094–8.
7.
go back to reference Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210–21. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210–21.
8.
go back to reference Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008;451:937–42. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008;451:937–42.
9.
go back to reference Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005;111: 2198–202. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005;111: 2198–202.
10.
go back to reference Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with sixmonth follow-up. J Am Coll Cardiol. 2003;42:2063–9. Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with sixmonth follow-up. J Am Coll Cardiol. 2003;42:2063–9.
11.
go back to reference Vale PR, Losordo DW, Milliken CE, McDonald MC, Gravelin LM, Curry CM, et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation. 2001;103:2138–43. Vale PR, Losordo DW, Milliken CE, McDonald MC, Gravelin LM, Curry CM, et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation. 2001;103:2138–43.
12.
go back to reference Tio RA, Tkebuchava T, Scheuermann TH, Lebherz C, Magner M, Kearny M, et al. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Hum Gene Ther. 1999;10:2953–60. Tio RA, Tkebuchava T, Scheuermann TH, Lebherz C, Magner M, Kearny M, et al. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Hum Gene Ther. 1999;10:2953–60.
13.
go back to reference Grothues F, Wolfram O, Fantoni C, Boenigk H, Gotte A, Tempelmann C, et al. Volume measurement by CARTO compared with cardiac magnetic resonance. Europace. 2006;8:37–41. Grothues F, Wolfram O, Fantoni C, Boenigk H, Gotte A, Tempelmann C, et al. Volume measurement by CARTO compared with cardiac magnetic resonance. Europace. 2006;8:37–41.
14.
go back to reference Van Langenhove G, Hamburger JN, Smits PC, Albertal M, Onderwater E, Kay IP, et al. Evaluation of left ventricular volumes and ejection fraction with a nonfluoroscopic endoventricular three-dimensional mapping technique. Am Heart J. 2000;140:596–602. Van Langenhove G, Hamburger JN, Smits PC, Albertal M, Onderwater E, Kay IP, et al. Evaluation of left ventricular volumes and ejection fraction with a nonfluoroscopic endoventricular three-dimensional mapping technique. Am Heart J. 2000;140:596–602.
15.
go back to reference Hirsch A, Nijveldt R, Van der Vleuten PA, Biemond BJ, Doevendans PA, van Rossum AC, et al. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial - a prospective, multicenter, randomized trial. Am Heart J. 2006;152:434–41. Hirsch A, Nijveldt R, Van der Vleuten PA, Biemond BJ, Doevendans PA, van Rossum AC, et al. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial - a prospective, multicenter, randomized trial. Am Heart J. 2006;152:434–41.
16.
go back to reference Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–10. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–10.
Metagegevens
Titel
Evaluation of global left ventricular function assessment of non-fluorescent electromechanical endocardial mapping compared with biplane left ventricular contrast angiography
Auteurs
E-S Tan
P. A. Van der Vleuten
G. A. J. Jessurun
R. A. Tio
F. Zijlstra
I. C. Van Gelder
Publicatiedatum
01-02-2010
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Netherlands Heart Journal / Uitgave 2/2010
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/BF03091741